NI201800040A - Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue - Google Patents
Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengueInfo
- Publication number
- NI201800040A NI201800040A NI201800040A NI201800040A NI201800040A NI 201800040 A NI201800040 A NI 201800040A NI 201800040 A NI201800040 A NI 201800040A NI 201800040 A NI201800040 A NI 201800040A NI 201800040 A NI201800040 A NI 201800040A
- Authority
- NI
- Nicaragua
- Prior art keywords
- inhibitors
- compounds
- mono
- dengue
- disustituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere a compuestos indólicos mono- o disustituidos, a métodos para prevenir o tratar infecciones virales por dengue utilizando dichos compuestos y también se refiere a dichos compuestos para su uso como una medicina, más preferentemente para su uso como una medicina para tratar o prevenir infecciones virales por dengue. La presente invención se refiere además a composiciones farmacéuticas o preparados combinados de los compuestos, a las composiciones o preparados para su uso como una medicina, más preferentemente para la prevención o el tratamiento de infecciones virales por dengue. La invención también se refiere a procesos para la preparación de los compuestos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15185522 | 2015-09-16 | ||
| EP16163465 | 2016-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201800040A true NI201800040A (es) | 2018-07-24 |
Family
ID=56958913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201800040A NI201800040A (es) | 2015-09-16 | 2018-03-15 | Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US10786484B2 (es) |
| EP (1) | EP3350163B1 (es) |
| JP (2) | JP7045984B2 (es) |
| KR (1) | KR102676442B1 (es) |
| CN (1) | CN108368044B (es) |
| AU (1) | AU2016323535B2 (es) |
| CA (1) | CA2996856C (es) |
| CL (1) | CL2018000697A1 (es) |
| CO (1) | CO2018003369A2 (es) |
| CR (1) | CR20180214A (es) |
| CY (1) | CY1122792T1 (es) |
| DK (1) | DK3350163T3 (es) |
| EA (1) | EA035679B1 (es) |
| EC (1) | ECSP18020039A (es) |
| ES (1) | ES2778431T3 (es) |
| HK (1) | HK1258320A1 (es) |
| HR (1) | HRP20200408T1 (es) |
| IL (1) | IL258031B (es) |
| JO (1) | JO3633B1 (es) |
| LT (1) | LT3350163T (es) |
| MA (1) | MA42811B1 (es) |
| MD (1) | MD3350163T2 (es) |
| ME (1) | ME03674B (es) |
| MX (1) | MX2018003256A (es) |
| MY (1) | MY188347A (es) |
| NI (1) | NI201800040A (es) |
| PE (1) | PE20181007A1 (es) |
| PH (1) | PH12018500569B1 (es) |
| PL (1) | PL3350163T3 (es) |
| PT (1) | PT3350163T (es) |
| RS (1) | RS60039B1 (es) |
| SI (1) | SI3350163T1 (es) |
| SM (1) | SMT202000140T1 (es) |
| TW (1) | TWI758256B (es) |
| UA (1) | UA123672C2 (es) |
| UY (1) | UY36904A (es) |
| WO (1) | WO2017046258A1 (es) |
| ZA (1) | ZA201801764B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201116559D0 (en) | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| KR101818521B1 (ko) * | 2011-11-16 | 2018-01-16 | 대우조선해양 주식회사 | 마이크로채널 열교환기용 2상 유체 공급장치 및 그 방법 |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN114605327A (zh) | 2015-12-16 | 2022-06-10 | 洛克索肿瘤学股份有限公司 | 可用作激酶抑制剂的化合物 |
| CR20180496A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
| CN108884033B (zh) | 2016-03-31 | 2021-03-09 | 杨森制药公司 | 作为登革病毒复制抑制剂的经取代的吲哚衍生物 |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CA3013408A1 (en) | 2016-04-01 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180026A1 (ar) * | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| SI3630724T1 (sl) | 2017-05-22 | 2021-08-31 | Janssen Pharmaceuticals, Inc. | Substituirani derivati indolina kot zaviralci replikacije virusa denga |
| TWI758480B (zh) | 2017-05-22 | 2022-03-21 | 美商健生醫藥公司 | 作為登革熱病毒複製抑制劑之經取代之吲哚啉衍生物（二） |
| WO2024178504A1 (en) * | 2023-02-27 | 2024-09-06 | Enveric Biosciences Canada Inc. | Tri-halo-alkoxy-substituted tryptamine derivatives and methods of using |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0110832D0 (en) | 2001-05-03 | 2001-06-27 | Virogen Ltd | Antiviral compounds |
| US20050074457A1 (en) | 2001-12-12 | 2005-04-07 | Adeela Kamal | Assays and implements for determining and modulating hsp90 binding activity |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| ZA200705872B (en) | 2005-01-14 | 2008-09-25 | Genelabs Tecnologies Inc | Indole derivatives for treating viral infections |
| EA200701669A1 (ru) | 2005-02-09 | 2008-02-28 | Мидженикс Инк. | Композиции и способы лечения или предотвращения инфекций, вызванных вирусами семейства flaviviridae |
| FR2928645A1 (fr) * | 2008-03-14 | 2009-09-18 | Sanofi Aventis Sa | Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
| BRPI0909985A2 (pt) | 2008-06-03 | 2015-08-25 | Siga Technologies Inc | Composição farmacêutica e método para o tratamento ou profilaxia de uma infecção viral ou doença associada à mesma |
| PE20110368A1 (es) * | 2008-08-18 | 2011-06-13 | Univ Yale | Moduladores de mif |
| WO2010021878A1 (en) | 2008-08-19 | 2010-02-25 | Janssen Pharmaceutica Nv | Cold menthol receptor antagonists |
| TWI453207B (zh) | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| US8993604B2 (en) | 2009-06-30 | 2015-03-31 | Siga Technologies, Inc. | Treatment and prevention of dengue virus infections |
| NZ600816A (en) | 2010-01-15 | 2014-08-29 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
| JP5716205B2 (ja) | 2011-03-29 | 2015-05-13 | 学校法人日本大学 | グルコシダーゼ活性阻害用組成物及びそのスクリーニング方法 |
| GB201116559D0 (en) * | 2011-09-26 | 2011-11-09 | Univ Leuven Kath | Novel viral replication inhibitors |
| GB201305376D0 (en) | 2013-03-25 | 2013-05-08 | Univ Leuven Kath | Novel viral replication inhibitors |
| JP6030035B2 (ja) | 2013-09-27 | 2016-11-24 | 富士フイルム株式会社 | 蛍光観察装置、内視鏡システム及びプロセッサ装置並びに作動方法 |
| NZ717629A (en) * | 2013-10-23 | 2021-12-24 | Janssen Sciences Ireland Uc | Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
| CN110845498B (zh) | 2014-01-31 | 2023-02-17 | 百时美施贵宝公司 | 作为因子xia抑制剂的具有杂环p2′基团的大环化合物 |
| NO2721243T3 (es) | 2014-10-01 | 2018-10-20 | ||
| KR102478311B1 (ko) | 2014-10-01 | 2022-12-15 | 얀센 파마슈티칼즈, 인코포레이티드 | 뎅기 바이러스 복제 억제제로서의 １치환 또는 ２치환 인돌 유도체 |
| BR112017006708A2 (pt) | 2014-10-01 | 2017-12-26 | Janssen Pharmaceuticals Inc | indóis mono- ou dissubstituídos como inibidores da replicação viral de dengue |
| PH12017501272B1 (en) * | 2015-01-16 | 2023-01-11 | Janssen Pharmaceuticals Inc | Indole derivatives as dengue viral replication inhibitors |
| AR103680A1 (es) | 2015-02-23 | 2017-05-24 | Lilly Co Eli | Inhibidores selectivos de bace1 |
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20160198B1 (ar) | 2015-09-16 | 2022-03-14 | Janssen Pharmaceuticals Inc | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| PL3370698T3 (pl) | 2015-11-03 | 2022-04-25 | Zoetis Services Llc | Kompozyty polimerowe zol-żel i ich zastosowania |
| CR20180496A (es) | 2016-03-31 | 2018-12-06 | Univ Leuven Kath | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue |
| MX2018011729A (es) | 2016-03-31 | 2019-01-10 | Takeda Pharmaceuticals Co | Compuesto heterociclico. |
| CN108884033B (zh) | 2016-03-31 | 2021-03-09 | 杨森制药公司 | 作为登革病毒复制抑制剂的经取代的吲哚衍生物 |
| KR102356433B1 (ko) | 2016-04-01 | 2022-01-27 | 시그날 파마소티칼 엘엘씨 | 치환된 아미노퓨린 화합물, 이의 조성물, 및 그것에 의한 치료 방법 |
| ES2928005T3 (es) | 2016-04-01 | 2022-11-14 | Basf Se | Compuestos bicíclicos |
| CR20240116A (es) | 2016-04-01 | 2024-04-12 | Kite Pharma Inc | RECEPTORES QUIMÉRICOS DE FLT3 Y MÉTODOS DE USO DE LOS MISMOS (Divisional 2018-518) |
| JOP20170069B1 (ar) | 2016-04-01 | 2021-08-17 | 1 Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| TWI787599B (zh) | 2016-04-01 | 2022-12-21 | 美商凱特製藥公司 | 嵌合抗原和ｔ細胞受體及使用方法 |
| MY197669A (en) | 2016-04-01 | 2023-07-03 | Amgen Inc | Chimeric receptors and methods of use thereof |
| CA3013408A1 (en) | 2016-04-01 | 2017-10-05 | Janssen Pharmaceuticals, Inc. | Substituted indole compound derivatives as dengue viral replication inhibitors |
| JOP20180026A1 (ar) | 2017-03-31 | 2019-01-30 | Univ Leuven Kath | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| JOP20180025B1 (ar) | 2017-03-31 | 2021-08-17 | Janssen Pharmaceuticals Inc | مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| TWI758480B (zh) | 2017-05-22 | 2022-03-21 | 美商健生醫藥公司 | 作為登革熱病毒複製抑制劑之經取代之吲哚啉衍生物（二） |
| SI3630724T1 (sl) | 2017-05-22 | 2021-08-31 | Janssen Pharmaceuticals, Inc. | Substituirani derivati indolina kot zaviralci replikacije virusa denga |
-
2016
- 2016-09-06 JO JOP/2016/0197A patent/JO3633B1/ar active
- 2016-09-13 TW TW105129691A patent/TWI758256B/zh not_active IP Right Cessation
- 2016-09-15 ME MEP-2020-53A patent/ME03674B/me unknown
- 2016-09-15 JP JP2018513845A patent/JP7045984B2/ja active Active
- 2016-09-15 CN CN201680053589.9A patent/CN108368044B/zh active Active
- 2016-09-15 SM SM20200140T patent/SMT202000140T1/it unknown
- 2016-09-15 RS RS20200272A patent/RS60039B1/sr unknown
- 2016-09-15 MY MYPI2018000378A patent/MY188347A/en unknown
- 2016-09-15 MD MDE20180704T patent/MD3350163T2/ro unknown
- 2016-09-15 PE PE2018000391A patent/PE20181007A1/es unknown
- 2016-09-15 LT LTEP16767235.1T patent/LT3350163T/lt unknown
- 2016-09-15 DK DK16767235.1T patent/DK3350163T3/da active
- 2016-09-15 MA MA42811A patent/MA42811B1/fr unknown
- 2016-09-15 US US15/759,844 patent/US10786484B2/en active Active
- 2016-09-15 EP EP16767235.1A patent/EP3350163B1/en active Active
- 2016-09-15 MX MX2018003256A patent/MX2018003256A/es unknown
- 2016-09-15 CR CR20180214A patent/CR20180214A/es unknown
- 2016-09-15 SI SI201630686T patent/SI3350163T1/sl unknown
- 2016-09-15 EA EA201890723A patent/EA035679B1/ru not_active IP Right Cessation
- 2016-09-15 UA UAA201804016A patent/UA123672C2/uk unknown
- 2016-09-15 CA CA2996856A patent/CA2996856C/en active Active
- 2016-09-15 ES ES16767235T patent/ES2778431T3/es active Active
- 2016-09-15 KR KR1020187009485A patent/KR102676442B1/ko active IP Right Grant
- 2016-09-15 AU AU2016323535A patent/AU2016323535B2/en active Active
- 2016-09-15 PT PT167672351T patent/PT3350163T/pt unknown
- 2016-09-15 PH PH1/2018/500569A patent/PH12018500569B1/en unknown
- 2016-09-15 PL PL16767235T patent/PL3350163T3/pl unknown
- 2016-09-15 WO PCT/EP2016/071852 patent/WO2017046258A1/en active Application Filing
- 2016-09-16 UY UY0001036904A patent/UY36904A/es not_active Application Discontinuation
-
2018
- 2018-03-12 IL IL258031A patent/IL258031B/en active IP Right Grant
- 2018-03-14 EC ECIEPI201820039A patent/ECSP18020039A/es unknown
- 2018-03-15 NI NI201800040A patent/NI201800040A/es unknown
- 2018-03-15 ZA ZA2018/01764A patent/ZA201801764B/en unknown
- 2018-03-15 CL CL2018000697A patent/CL2018000697A1/es unknown
- 2018-03-26 CO CONC2018/0003369A patent/CO2018003369A2/es unknown
-
2019
- 2019-01-16 HK HK19100688.6A patent/HK1258320A1/zh not_active IP Right Cessation
-
2020
- 2020-03-12 HR HRP20200408TT patent/HRP20200408T1/hr unknown
- 2020-03-12 CY CY20201100216T patent/CY1122792T1/el unknown
-
2021
- 2021-08-20 JP JP2021135171A patent/JP2021193092A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22023220A (es) | Derivados de indol mono o disustituidos como inhibidores de la replicación viral del dengue | |
| NI201800040A (es) | Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue | |
| NI201800039A (es) | Derivados de indol mono- o disustituidos como inhibidores de la replicación viral del dengue | |
| ECSP18073245A (es) | Derivados de indol sustituidos como inhibidores de la replicación vírica del dengue | |
| ECSP18073264A (es) | Derivados de compuestos de indol sustituidos como inhibidores de la replicación vírica del dengue | |
| ECSP18073293A (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
| CO2019010295A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CO2019013042A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| ECSP18073366A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CL2017000782A1 (es) | Derivados de indol mono- o disustituidos como inhibidores de la replicación del virus del dengue | |
| CL2017001822A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
| CO2019012035A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| CO2019010292A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| UY36339A (es) | Indoles mono o disustituidos como inhibidores de la replicación del virus del dengue |